Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in Healthy Adults in South Africa
The Journal of Infectious Diseases2008Vol. 198(4), pp. 544–552
Citations Over TimeTop 10% of 2008 papers
Tony Hawkridge, Thomas J. Scriba, Sebastian Gelderbloem, Erica Smit, Michèle Tameris, Sizulu Moyo, Trudie Lang, Ashley Veldsman, Mark Hatherill, Linda van der Merwe, Helen A. Fletcher, Hassan Mahomed, Adrian V. S. Hill, Willem A. Hanekom, Gregory Hussey, Helen McShane
Abstract
ClinicalTrials.gov identifier: NCT00460590.
Related Papers
- → Immunogenicity and Protective Efficacy of the DAR-901 Booster Vaccine in a Murine Model of Tuberculosis(2016)63 cited
- → Vaccination Against Tuberculosis With Whole-Cell Mycobacterial Vaccines(2016)58 cited
- → Integrating fish models in tuberculosis vaccine development(2020)13 cited
- → Circulating B-Lymphocytes as Potential Biomarkers of Tuberculosis Infection Activity(2014)26 cited
- → The effect of tuberculin skin test and BCG vaccination on the expansion of PPD-specific IFN-γ producing cells ex vivo(2007)11 cited